HC Wainwright & Co. Maintains Buy on 89bio, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Ed Arce has maintained a Buy rating on 89bio (NASDAQ:ETNB) but has reduced the price target from $35 to $32.
December 20, 2023 | 5:44 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. maintains a Buy rating on 89bio but lowers the price target from $35 to $32, indicating a positive outlook with a slightly reduced growth expectation.
While the Buy rating suggests that HC Wainwright & Co. still sees 89bio as a good investment, the reduction in the price target may reflect a more conservative view on the company's growth prospects or market conditions. This could lead to a neutral short-term impact on the stock as the positive sentiment from the Buy rating is somewhat offset by the lower price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100